Comparison of Hemodynamic Effects of Hypobaric and Hyperbaric Bupivacaine in Spinal Anesthesia in Geriatric Patients
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · May 13, 2025
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how two different types of spinal anesthesia—hypobaric and hyperbaric bupivacaine—affect blood pressure in older patients undergoing hip surgery. As people age, they often experience more drops in blood pressure during surgery, which can be a concern. The goal of this study is to find out if one type of anesthesia leads to better blood pressure control than the other in geriatric patients.
To be eligible for this trial, participants need to be over 65 years old and undergoing surgery for a femur fracture while lying down. They should also be classified as ASA class I to III, which means they have mild to moderate health issues. However, patients with certain conditions, such as allergies to the medication, bleeding disorders, or infections at the injection site, will not be able to participate. If you join the study, you can expect to receive either type of anesthesia and help researchers understand which is safer for older patients during hip surgery. This study has not started recruiting participants yet, but it aims to provide important insights for better care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 65 years of age
- • Patients taken to surgery in a supine position due to femur fractures
- • Patients classified as ASA (American Society of Anesthesiologists) class I-III
- Exclusion Criteria:
- • History of allergy to the drug
- • Patients with coagulopathy
- • Patients refusing to participate in the study
- • Severe valve stenosis
- • Infection at the injection site
- • Inadequate spinal anesthesia level during surgery
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eski̇şehi̇r, Odunpazari, Turkey
Patients applied
Trial Officials
Sacit Güleç, Professor
Study Director
Eskisehir Osmangazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported